Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients

We employed a customized Multiple Myeloma (MM)-specific Mutation Panel (M(3)P) to screen a homogenous cohort of 142 untreated MM patients for relevant mutations in a selection of disease-specific genes. M(3)Pv2.0 includes 77 genes selected for being either actionable targets, potentially related to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kortuem, K M, Braggio, E, Bruins, L, Barrio, S, Shi, C S, Zhu, Y X, Tibes, R, Viswanatha, D, Votruba, P, Ahmann, G, Fonseca, R, Jedlowski, P, Schlam, I, Kumar, S, Bergsagel, P L, Stewart, A K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771964/
https://www.ncbi.nlm.nih.gov/pubmed/26918361
http://dx.doi.org/10.1038/bcj.2016.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771964/
https://www.ncbi.nlm.nih.gov/pubmed/26918361
http://dx.doi.org/10.1038/bcj.2016.1

Ejemplares similares